Selected Grants
Stimulating Access to Research in Residency (StARR) - NIAID
Inst. Training Prgm or CMEPreceptor · Awarded by National Institutes of Health · 2018 - 2029Duke Research Training Program in Surgical Oncology
Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2024 - 2029Project 3: RNA Aptamers as Probes and Regulators of Coagulation
ResearchPrincipal Investigator · Awarded by Children's Hospital of Philadelphia · 2018 - 2029Advanced Immunobiology Traning Program for Surgeons
Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2019 - 2029Utilizing nucleic acid scavengers to elucidate how DNA/RNA-containing DAMPs promote pancreatic cancer metastasis and to mitigate such processes
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2024 - 2029Stimulating Access to Research in Residency (StARR) - NHLBI
Inst. Training Prgm or CMEPreceptor · Awarded by National Heart, Lung, and Blood Institute · 2018 - 2028Directed Evolution of gRNA Variants to Improve CRISPR Gene Editing Efficiency for Gene Therapy Applications
FellowshipPrincipal Investigator · Awarded by National Human Genome Research Institute · 2024 - 2027Medical Scientist Training Program
Inst. Training Prgm or CMEPreceptor · Awarded by National Institute of General Medical Sciences · 2022 - 2027University Training Program in Biomolecular and Tissue Engineering
Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 1994 - 2027Elucidating and mitigating the effects of Damage Associated Molecular Patterns (DAMPs) released following severe traumatic injury.
ResearchPrincipal Investigator · Awarded by Department of Defense · 2024 - 2026Cell and Molecular Biology Training Program
Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2021 - 2026Hematology & Transfusion Medicine (T32)
Inst. Training Prgm or CMEPreceptor · Awarded by National Institutes of Health · 1975 - 2026Genetic and Genomics Training Grant
Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2020 - 2025Pharmacological Sciences Training Grant
Inst. Training Prgm or CMEPreceptor · Awarded by National Institutes of Health · 2020 - 2025NINDS Research Education Programs for Residents and Fellows in Neurosurgery
Inst. Training Prgm or CMEMentor · Awarded by National Institute of Neurological Disorders and Stroke · 2009 - 2025Reducing prostate cancer aggressiveness via aptamer-mediated nuclear delivery of splice-switching oligonucleotides
ResearchPrincipal Investigator · Awarded by Johns Hopkins University · 2023 - 2025Viral Oncology Training Grant
Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 1980 - 2025Aptamer-small molecule conjugate as potent and reversible surgical anticoagulants
FellowshipPrincipal Investigator · Awarded by American Heart Association · 2023 - 2024Cas9 RNP delivery to immune cells in vivo via molecular targeting
ResearchPrincipal Investigator · Awarded by University of California - Berkeley · 2019 - 2024Engineering Polymers to Scavenge DAMPs in Arthritis and Lupus
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2018 - 2024Regional Oncolytic Poliovirus Immunotherapy for Breast Cancer
ResearchInvestigator · Awarded by Department of Defense · 2016 - 2024Direct Detection and Characterization of Blood Clots In Vivo
ResearchPrincipal Investigator · Awarded by University of California - Davis · 2019 - 2023Targeting mitochondrial dysfunction and damage-associated molecular patterns to improve the function of high risk grafts in liver transplantation
ResearchCo-Mentor · Awarded by National Institutes of Health · 2020 - 2022Medical Scientist Training Program
Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 1997 - 2022Reducing prostate cancer aggressiveness via aptamer-mediated nuclear delivery of splice-switching oligonucleotides
ResearchCo Investigator · Awarded by Department of Defense · 2020 - 2022Utilizing Nucleic Acid Binding Polymers to Ameliorate Inflammation-driven Metastatic Progression in Breast Cancer
FellowshipPrincipal Investigator · Awarded by National Institutes of Health · 2018 - 2021Targeting DAMP-induced inflammation to prevent metastasis
ResearchPartnering PI · Awarded by Department of Defense · 2016 - 2020Targeting DAMP-induced inflammation to prevent metastasis
ResearchPrincipal Investigator · Awarded by Department of Defense · 2016 - 2020POEGMA Conjugation of Aptamers
ResearchPrincipal Investigator · Awarded by Gateway Bio, Inc. · 2018 - 2020Genetics Training Grant
Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 1979 - 2020Organization and Function of Cellular Structure
Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 1975 - 2020Antithrombotic Aptamers and Antidotes
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2000 - 2020Aptamer-based Detection and Binding of Peptide-MHC
ResearchPrincipal Investigator · Awarded by MD Anderson Cancer Center · 2018 - 2019APTAMER BEACONS FOR EPIGENETIC HIGH-THROUGHOUT ASSAY DEVELOPMENT
ResearchPrincipal Investigator · Awarded by EpiCypher, Inc. · 2018 - 2019Duke-UNC Clinical Hematology and Transfusion Research Career Development Program
ResearchMentor · Awarded by National Institutes of Health · 2006 - 2019DTMI-Center for Thrombotic and Hemostatic Disorders
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2012 - 2019Neutralizing Antibody & AAV VIX Gene Therapy
ResearchPrincipal Investigator · Awarded by University of North Carolina - Chapel Hill · 2017 - 2019Next-Generation Detection Reagents for Chromatin Immunoprecipitation
ResearchPrincipal Investigator · Awarded by EpiCypher, Inc. · 2017 - 2018Studying Anticoagulant Synergy of Factor Xa Aptamer and Catalytic Site Inhibitors
FellowshipPrincipal Investigator · Awarded by National Institutes of Health · 2015 - 2018TRC-THD Administrative Coordinating Center (ACC)
ResearchCo-Principal Investigator · Awarded by National Institutes of Health · 2012 - 2017Aptamer Targeted Drug and Toxin Delivery to Prostate Cancer
FellowshipMentor · Awarded by Department of Defense · 2014 - 2016Targeting DNA Neutrophil Extracellular Traps in Sickle Cell Disease
ResearchPrincipal Investigator · Awarded by University of North Carolina - Chapel Hill · 2013 - 2016Research Training In Neuro-Oncology
Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 1998 - 2016Using Aptamer Coated Nanoparticles Encapsulating Prostate Tumor Antigen Encoding mRNA to Target Dendritic Cells In Vivo
ResearchPartnering PI · Awarded by Department of Defense · 2012 - 2015RNA Therapeutics for Pancreatic Cancer
ResearchMentor · Awarded by National Institutes of Health · 2011 - 2015Anticoagulant Synergy of Factor Xa Aptamer and Catalytic Site Inhibitors: Mechanistic and Translational Studies
FellowshipPrincipal Investigator · Awarded by PhRMA Foundation · 2015 - 2015In Vivo Selection of Tumor-Specific RNA Binding Motifs
ResearchCollaborator · Awarded by National Institutes of Health · 2011 - 2015Regulation of inflammatory responses by nucleic-acid binding polymers
FellowshipPrincipal Investigator · Awarded by National Institutes of Health · 2012 - 2014RNA aptamers as cell surface receptor agonists and siRNA delivery agents
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2009 - 2014Nucleic Acid Binding Polymers as Anti-Inflammatory Agents
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2011 - 2013CTSA UL
ResearchDirector · Awarded by National Institutes of Health · 2006 - 2012In Vivo Selection of Aptamers Targeting Pancreatic Cancer
FellowshipPrincipal Investigator · Awarded by National Institutes of Health · 2011 - 2012Research Training In Neuro-Oncology
Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2005 - 2010Development and Analysis of Aptamer-Antidote Pairs
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2000 - 2010Enhancement of Thrombolysis through Inhibition of PAI-1 and Antiplasmin
FellowshipPrincipal Investigator · Awarded by National Institutes of Health · 2007 - 2008E2F-Mediated Control of Vascular Growth and Remodeling
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2003 - 2008The Angiopoietins in Vascular Maintenance and Remodeling
ResearchConsultant · Awarded by National Institutes of Health · 2002 - 2007Analysis of Group I and II Introns in Mammalian Cells
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 1995 - 2007Development of Oligonucleotide-based CTLA-4 Inhibitors.
ResearchCo Investigator · Awarded by National Institutes of Health · 2004 - 2006Disrupting Viral Gene with Group II Introns
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2001 - 2006Rna Ligands: E2f Function and Cell Proliferation
ResearchCo-Principal Investigator · Awarded by National Institutes of Health · 1999 - 2003Developing RNA-Mimotopes Of Hiv Antigens
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 1998 - 2001Ribozyme Mediated Repair of Sickle B-Globin Transcripts
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 1996 - 2001Trans-splicing by a Group I Ribozyme in Mammalial Cells.
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 1998 - 2001Probing expressed genome organization with ribozymes
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 1997 - 2000Ribozyme-Mediated Repair Of Sickle B-Globin Transcripts
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 1996 - 1999Trans Splicing By A Group I Ribozyme In Mammalian Cells
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 1996 - 1999Trans-Splicing By A Group I Ribozyme In Mammalian Cells
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 1995 - 1999External Relationships
- A M Pappas Ventures
- AZURNA
- Basking Biosciences
- Dragon Therapeutics
- Eli Lilly & Co.
- Rznomics Inc
- Somalogic
- Upstream Therapeutics
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.